B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 5.35 THB Market Closed
Market Cap: 3.2B THB
Have any thoughts about
Bangkok Lab and Cosmetic PCL?
Write Note

Balance Sheet

Balance Sheet Decomposition
Bangkok Lab and Cosmetic PCL

Current Assets 1.7B
Cash & Short-Term Investments 955.5m
Receivables 347.5m
Other Current Assets 401.1m
Non-Current Assets 508.2m
PP&E 425.7m
Intangibles 9.9m
Other Non-Current Assets 72.6m
Current Liabilities 376.2m
Accounts Payable 107.7m
Short-Term Debt 104.4m
Other Current Liabilities 164.1m
Non-Current Liabilities 220.8m
Long-Term Debt 69.9m
Other Non-Current Liabilities 150.9m

Balance Sheet
Bangkok Lab and Cosmetic PCL

Rotate your device to view
Balance Sheet
Currency: THB
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
10
8
22
38
90
Cash Equivalents
2
10
8
22
38
90
Short-Term Investments
0
0
0
0
0
885
Total Receivables
180
324
302
254
312
369
Accounts Receivables
179
294
288
245
302
347
Other Receivables
1
30
15
9
10
22
Inventory
137
257
340
344
401
393
Other Current Assets
0
3
4
5
7
7
Total Current Assets
319
594
655
624
757
1 744
PP&E Net
243
317
332
385
384
415
Intangible Assets
4
5
5
5
4
7
Other Long-Term Assets
31
75
68
65
68
74
Total Assets
596
N/A
991
+66%
1 059
+7%
1 079
+2%
1 213
+12%
2 240
+85%
Liabilities
Accounts Payable
89
128
124
106
153
96
Short-Term Debt
227
397
402
388
379
200
Current Portion of Long-Term Debt
32
40
43
76
62
58
Other Current Liabilities
28
93
99
80
122
87
Total Current Liabilities
376
659
669
650
715
442
Long-Term Debt
38
64
146
107
104
76
Deferred Income Tax
0
0
0
8
0
0
Minority Interest
0
11
9
9
13
20
Other Liabilities
32
104
110
108
113
127
Total Liabilities
445
N/A
839
+88%
934
+11%
881
-6%
944
+7%
665
-30%
Equity
Common Stock
130
130
180
200
240
300
Retained Earnings
21
29
55
32
2
97
Additional Paid In Capital
0
0
0
0
0
1 148
Other Equity
0
51
0
31
31
31
Total Equity
151
N/A
153
+1%
125
-18%
198
+58%
268
+35%
1 576
+487%
Total Liabilities & Equity
596
N/A
991
+66%
1 059
+7%
1 079
+2%
1 213
+12%
2 240
+85%
Shares Outstanding
Common Shares Outstanding
150
150
150
150
150
600

See Also

Discover More